VIDAZA
Swiss trademark · 507246 · Word mark · In force
Register entry
- Registration number
- 507246
- Application number
- 10849/2002
- Status
- In force
- Type
- Word mark
- Filed
- Dec 23, 2002
- Registered
- Feb 3, 2003
- Published
- Feb 18, 2003
- Protected until
- Dec 23, 2032
- Priority
- 24.06.2002 US
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate für die Behandlung von Blutkrankheiten und Krebs.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 21, 2022
Renewed
Published in Swissreg on 21.11.2022
- Jun 22, 2021
Agent removed
- Representative
- Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)
Published in Swissreg on 22.06.2021
- Jun 22, 2021
Agent entered
- Representative
- Troller Hitz Troller, Rechtsanwälte, Schweizerhofquai 2, Postfach, 6002 Luzern
Published in Swissreg on 22.06.2021
- Jul 11, 2012
Renewed
Published in Swissreg on 11.07.2012
- Sep 2, 2008
Transferred
- Owner
- Pharmion Corporation, 2525 28th Street, Boulder (CO 80301), USA → Celgene Corporation, 86 Morris Avenue, Summit, New Jersey 07901, USA
Published in Swissreg on 02.09.2008
- Jun 23, 2008
Agent entered
- Representative
- BOHEST AG, Postfach 160, 4003 Basel → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex
Published in the SOGC no. 119 of 23.06.2008
- May 5, 2008
Agent’s address changed
- Representative
- A. Braun, Braun, Héritier, Eschmann AG, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel
Published in the SOGC no. 85 of 05.05.2008
- Feb 18, 2003
Registered
Published in the SOGC no. 32 of 18.02.2003
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.